Capabilities
A connected approach to scientific market development
KTD brings scientific evaluation, regulatory planning, commercialization, and market-development coordination into one structured approach for international medical manufacturers evaluating Iran.
- Scientific Expertise
- Regulatory Capability
- Commercialization
- Market Growth
From product understanding to responsible market development
A credible market-entry strategy begins with understanding the technology, its evidence, its regulatory context, and the realities of the intended market. KTD helps manufacturers examine these dimensions together before defining an appropriate partnership pathway.
The scope of work is determined by the product, applicable regulations, available evidence, commercial conditions, and the approved responsibilities of each party.
Capability 01
Scientific Expertise
Scientific understanding provides the foundation for credible positioning and responsible decision-making.
-
Product and technology review
Reviewing the product concept, intended use, technical characteristics, and available supporting evidence.
-
Clinical and professional context
Considering relevant clinical workflows, professional users, and the product’s potential role within the local healthcare environment.
-
Evidence and claim assessment
Examining whether proposed scientific and marketing statements are appropriately supported and suitable for further review.
-
Scientific positioning
Helping define a clear, evidence-conscious value proposition for relevant professional audiences.
KTD’s scientific evaluation does not replace independent clinical, laboratory, legal, or regulatory assessment where such review is required.
Capability 02
Regulatory Capability
Regulatory planning helps determine whether a product has a realistic and appropriately documented pathway for the Iranian market.
-
Preliminary pathway assessment
Identifying the likely product category, registration considerations, and major documentation requirements.
-
Documentation readiness review
Reviewing the availability and organization of manufacturer, quality, technical, clinical, and authorization documents.
-
Submission coordination
Supporting an agreed documentation and communication process with relevant local regulatory participants.
-
Regulatory lifecycle awareness
Considering post-registration responsibilities, document validity, changes, renewals, and ongoing compliance requirements.
Regulatory requirements and authority decisions remain subject to applicable law, official procedures, product classification, and review by the relevant authorities. KTD does not guarantee approval or registration timelines.
Capability 03
Commercialization
Commercial planning translates product potential into a market approach adapted to local channels and stakeholder expectations.
-
Market landscape evaluation
Examining relevant segments, alternatives, professional demand, channel structure, and potential adoption barriers.
-
Route-to-market planning
Evaluating appropriate distribution, tender, institutional, professional, or direct-development pathways where applicable.
-
Positioning and launch preparation
Coordinating scientific messages, commercial priorities, educational needs, and launch-readiness considerations.
-
Partnership model evaluation
Defining practical responsibilities, information requirements, decision points, and commercial assumptions for further negotiation.
Capability 04
Market Growth
Responsible market development continues beyond initial introduction and requires learning, coordination, and disciplined follow-through.
-
Professional engagement
Supporting appropriate communication and educational engagement with relevant healthcare communities.
-
Market feedback
Collecting structured commercial and professional observations to inform partnership decisions and positioning.
-
Performance review
Reviewing agreed indicators, implementation progress, constraints, and priorities with the manufacturer.
-
Development opportunities
Evaluating selected portfolio, localization, training, or regional opportunities when justified by evidence and partnership scope.
Market growth depends on regulatory status, product performance, commercial terms, market conditions, execution, and decisions by independent stakeholders. No sales or adoption outcome is guaranteed.
Connected process
How the capabilities work together
-
Understand
Product, evidence, intended use, and manufacturer objectives
-
Evaluate
Scientific relevance, documentation readiness, and market conditions
-
Define
Regulatory pathway, commercial logic, responsibilities, and decision criteria
-
Coordinate
Approved scientific, regulatory, and market-development activities
-
Review
Progress, evidence, feedback, risks, and next decisions
Progression between stages depends on the evidence available, regulatory feasibility, commercial alignment, and approval by the relevant parties.
Engagement boundaries
Clear responsibilities, defined for each engagement
KTD may coordinate
- scientific and market evaluation
- preliminary regulatory planning
- documentation workflows
- partnership and commercialization planning
- approved professional engagement
The manufacturer remains responsible for
- accurate and complete product information
- technical and quality documentation
- manufacturing and product compliance
- authorized claims
- contractual commitments and continuing support
Other qualified parties may be required for
- official regulatory decisions
- legal or tax advice
- independent testing
- clinical evaluation
- specialized manufacturing or localization activities
Capabilities may be delivered by KTD, coordinated with legally independent members of its strategic network, or supported by qualified external specialists, according to the approved scope of each engagement.
Business-area relevance
Applied across focused healthcare sectors
-
Diagnostics
Scientific and market-entry support informed by laboratory workflows, diagnostic evidence, quality requirements, and professional use contexts.
-
Regenerative Medicine
Structured evaluation of regenerative and cell-related healthcare technologies within applicable scientific, ethical, and regulatory boundaries.
-
Aesthetic Medicine
Evidence-conscious evaluation, professional positioning, and commercial planning for medical aesthetic technologies.
Begin with a structured evaluation
If you are considering Iran for a medical technology, the first step is to understand the product, available evidence, regulatory context, and commercial objectives.